DARIUSZ STANISLAW WODKA,DAVID ANDREW COATES,JEFFREY ALAN PETERSON,JEFFREY MICHAEL SCHKERYANTZ,JOHN ROWLEY WETTERAU II,KEVIN ROBERT FALES,MATTHEW JOHN VALLI,QUANRONG SHEN,YANGPING XU
申请号：
BR112019000929
公开号：
BR112019000929A2
申请日:
2017.08.08
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention relates to compounds of formula (a), pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using such compounds, salts or compositions to treat hyperphosphataemia, chronic kidney disease and / or cardiovascular disease associated with chronic kidney disease. .a presente invenção refere-se a compostos da fórmula (a), sais farmaceuticamente aceitáveis, composições farmacêuticas dos mesmos e métodos de uso desses compostos, sais ou composições para tratar hiperfosfatemia, doença renal crônica e/ou a doença cardiovascular associada com doença renal crônica.
